23 May 2013
Keywords: cytogen, quadramet, toxicity, via, ilp, usa-based, corp
Article | 17 April 2006
USA-based Cytogen Corp says that preclinical data on Quadramet (samarium Sm-153 lexidronam injection), suggest that the agent, which is currently
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 April 2006
10 April 2006
22 May 2013
© 2013 thepharmaletter.com